Clinical importance of the EMSY gene expression and polymorphisms in ovarian cancer

EMSY, a BRCA2–associated protein, is amplified and overexpressed in various sporadic cancers. This is the first study assessing the clinical impact of its expression and polymorphisms on ovarian cancer (OvCa) outcome in the context of the chemotherapy regimen used. In 134 frozen OvCa samples, we ass...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Dansonka-Mieszkowska, Agnieszka, Szafron, Lukasz M., Moes-Sosnowska, Joanna, Kulinczak, Mariusz, Balcerak, Anna, Konopka, Bozena, Kulesza, Magdalena, Budzilowska, Agnieszka, Lukasik, Martyna, Piekarska, Urszula, Rzepecka, Iwona K., Parada, Joanna, Zub, Renata, Pienkowska-Grela, Barbara, Madry, Radoslaw, Siwicki, Jan K., Kupryjanczyk, Jolanta
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2018
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5915152/
https://ncbi.nlm.nih.gov/pubmed/29707144
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.24878
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller